Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 88

    1.

    Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.

    Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, Zhao R, Milstien S, Zhou H, Spiegel S, Takabe K.

    Cancer Res. 2012 Feb 1;72(3):726-35.

    PMID:
    22298596
    [PubMed - indexed for MEDLINE]
    2.

    Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells.

    Barone I, Catalano S, Gelsomino L, Marsico S, Giordano C, Panza S, Bonofiglio D, Bossi G, Covington KR, Fuqua SA, Andò S.

    Cancer Res. 2012 Mar 15;72(6):1416-27. Epub 2012 Jan 26.

    PMID:
    22282662
    [PubMed - indexed for MEDLINE]
    3.

    Mammographic breast density and breast cancer: evidence of a shared genetic basis.

    Varghese JS, Thompson DJ, Michailidou K, Lindström S, Turnbull C, Brown J, Leyland J, Warren RM, Luben RN, Loos RJ, Wareham NJ, Rommens J, Paterson AD, Martin LJ, Vachon CM, Scott CG, Atkinson EJ, Couch FJ, Apicella C, Southey MC, Stone J, Li J, Eriksson L, Czene K, Boyd NF, Hall P, Hopper JL, Tamimi RM; MODE Consortium, Rahman N, Easton DF.

    Cancer Res. 2012 Mar 15;72(6):1478-84. Epub 2012 Jan 19.

    PMID:
    22266113
    [PubMed - indexed for MEDLINE]
    4.

    Cathepsin B inhibition limits bone metastasis in breast cancer.

    Withana NP, Blum G, Sameni M, Slaney C, Anbalagan A, Olive MB, Bidwell BN, Edgington L, Wang L, Moin K, Sloane BF, Anderson RL, Bogyo MS, Parker BS.

    Cancer Res. 2012 Mar 1;72(5):1199-209. Epub 2012 Jan 19.

    PMID:
    22266111
    [PubMed - indexed for MEDLINE]
    5.

    Novel genetic markers of breast cancer survival identified by a genome-wide association study.

    Shu XO, Long J, Lu W, Li C, Chen WY, Delahanty R, Cheng J, Cai H, Zheng Y, Shi J, Gu K, Wang WJ, Kraft P, Gao YT, Cai Q, Zheng W.

    Cancer Res. 2012 Mar 1;72(5):1182-9. Epub 2012 Jan 9.

    PMID:
    22232737
    [PubMed - indexed for MEDLINE]
    6.

    Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage.

    Fitzgerald DP, Subramanian P, Deshpande M, Graves C, Gordon I, Qian Y, Snitkovsky Y, Liewehr DJ, Steinberg SM, Paltán-Ortiz JD, Herman MM, Camphausen K, Palmieri D, Becerra SP, Steeg PS.

    Cancer Res. 2012 Jan 1;72(1):144-53.

    PMID:
    22215693
    [PubMed - indexed for MEDLINE]
    7.

    Genetic variants in oxidative stress-related genes predict chemoresistance in primary breast cancer: a prospective observational study and validation.

    Yu KD, Huang AJ, Fan L, Li WF, Shao ZM.

    Cancer Res. 2012 Jan 15;72(2):408-19. Epub 2011 Dec 6.

    PMID:
    22147260
    [PubMed - indexed for MEDLINE]
    8.

    Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

    Eliassen AH, Spiegelman D, Xu X, Keefer LK, Veenstra TD, Barbieri RL, Willett WC, Hankinson SE, Ziegler RG.

    Cancer Res. 2012 Feb 1;72(3):696-706. Epub 2011 Dec 5.

    PMID:
    22144471
    [PubMed - indexed for MEDLINE]
    9.

    Role of JNK in mammary gland development and breast cancer.

    Cellurale C, Girnius N, Jiang F, Cavanagh-Kyros J, Lu S, Garlick DS, Mercurio AM, Davis RJ.

    Cancer Res. 2012 Jan 15;72(2):472-81. Epub 2011 Nov 29.

    PMID:
    22127926
    [PubMed - indexed for MEDLINE]
    10.

    Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells.

    Okuda H, Kobayashi A, Xia B, Watabe M, Pai SK, Hirota S, Xing F, Liu W, Pandey PR, Fukuda K, Modur V, Ghosh A, Wilber A, Watabe K.

    Cancer Res. 2012 Jan 15;72(2):537-47. Epub 2011 Nov 23.

    PMID:
    22113945
    [PubMed - indexed for MEDLINE]
    11.

    Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.

    McCartan D, Bolger JC, Fagan A, Byrne C, Hao Y, Qin L, McIlroy M, Xu J, Hill AD, Gaora PÓ, Young LS.

    Cancer Res. 2012 Jan 1;72(1):220-9. Epub 2011 Nov 9.

    PMID:
    22072566
    [PubMed - indexed for MEDLINE]
    12.

    Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.

    Hou X, Huang F, Macedo LF, Harrington SC, Reeves KA, Greer A, Finckenstein FG, Brodie A, Gottardis MM, Carboni JM, Haluska P.

    Cancer Res. 2011 Dec 15;71(24):7597-607. Epub 2011 Oct 31.

    PMID:
    22042792
    [PubMed - indexed for MEDLINE]
    13.

    Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.

    Mamessier E, Sylvain A, Bertucci F, Castellano R, Finetti P, Houvenaeghel G, Charaffe-Jaufret E, Birnbaum D, Moretta A, Olive D.

    Cancer Res. 2011 Nov 1;71(21):6621-32. Epub 2011 Sep 21.

    PMID:
    21937679
    [PubMed - indexed for MEDLINE]
    14.

    FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.

    Su JL, Cheng X, Yamaguchi H, Chang YW, Hou CF, Lee DF, Ko HW, Hua KT, Wang YN, Hsiao M, Chen PB, Hsu JM, Bast RC Jr, Hortobagyi GN, Hung MC.

    Cancer Res. 2011 Nov 1;71(21):6878-87. Epub 2011 Sep 12.

    PMID:
    21911455
    [PubMed - indexed for MEDLINE]
    15.

    In vivo magnetic resonance imaging of the estrogen receptor in an orthotopic model of human breast cancer.

    Pais A, Gunanathan C, Margalit R, Biton IE, Yosepovich A, Milstein D, Degani H.

    Cancer Res. 2011 Dec 15;71(24):7387-97. Epub 2011 Oct 31.

    PMID:
    22042793
    [PubMed - indexed for MEDLINE]
    16.

    Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes.

    Ha NH, Nair VS, Reddy DN, Mudvari P, Ohshiro K, Ghanta KS, Pakala SB, Li DQ, Costa L, Lipton A, Badwe RA, Fuqua S, Wallon M, Prendergast GC, Kumar R.

    Cancer Res. 2011 Dec 1;71(23):7259-69. Epub 2011 Oct 17.

    PMID:
    22006997
    [PubMed - indexed for MEDLINE]
    17.

    Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.

    Li Q, Shi L, Gui B, Yu W, Wang J, Zhang D, Han X, Yao Z, Shang Y.

    Cancer Res. 2011 Nov 1;71(21):6899-908. Epub 2011 Sep 21.

    PMID:
    21937684
    [PubMed - indexed for MEDLINE]
    18.

    Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations.

    Signori C, El-Bayoumy K, Russo J, Thompson HJ, Richie JP, Hartman TJ, Manni A.

    Cancer Res. 2011 Oct 1;71(19):6091-6. Epub 2011 Sep 20. Review.

    PMID:
    21933885
    [PubMed - indexed for MEDLINE]
    19.

    SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer.

    Elangovan S, Ramachandran S, Venkatesan N, Ananth S, Gnana-Prakasam JP, Martin PM, Browning DD, Schoenlein PV, Prasad PD, Ganapathy V, Thangaraju M.

    Cancer Res. 2011 Nov 1;71(21):6654-64. Epub 2011 Sep 15.

    PMID:
    21920899
    [PubMed - indexed for MEDLINE]
    20.

    A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.

    Fox EM, Miller TW, Balko JM, Kuba MG, Sánchez V, Smith RA, Liu S, González-Angulo AM, Mills GB, Ye F, Shyr Y, Manning HC, Buck E, Arteaga CL.

    Cancer Res. 2011 Nov 1;71(21):6773-84. Epub 2011 Sep 9.

    PMID:
    21908557
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk